These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7639296)

  • 1. Myasthenia gravis induced by alpha-interferon therapy.
    Pérez A; Perella M; Pastor E; Cano M; Escudero J
    Am J Hematol; 1995 Aug; 49(4):365-6. PubMed ID: 7639296
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon-alpha-induced pure red cell aplasia following chronic myelogenous leukemia.
    Tomita N; Motomura S; Ishigatsubo Y
    Anticancer Drugs; 2001 Jan; 12(1):7-8. PubMed ID: 11272289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolytic-uremic syndrome in a patient with chronic myelogenous leukemia treated with interferon alpha.
    Schlaifer D; Dumazer P; Spenatto N; Mignon-Conte M; Brousset P; Lumbroso C; Cooper M; Muller C; Huguet F; Attal M
    Am J Hematol; 1994 Nov; 47(3):254-5. PubMed ID: 7942805
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute pancreatitis associated with interferon alpha therapy for chronic myelogenous leukemia.
    Tannir NM; Talpaz M; Ghazal H; Proothi S; Kantarjian HM
    Leuk Lymphoma; 2000 Nov; 39(5-6):647-50. PubMed ID: 11342349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia.
    Fiorani C; Sacchi S; Bonacorsi G; Cosenza M
    Haematologica; 2000 Sep; 85(9):1006-7. PubMed ID: 10980653
    [No Abstract]   [Full Text] [Related]  

  • 6. 35-year-old patient with chronic myelogenous leukemia developing systemic lupus erythematosus after alpha-interferon therapy.
    Mehta ND; Hooberman AL; Vokes EE; Neeley S; Cotler S
    Am J Hematol; 1992 Oct; 41(2):141. PubMed ID: 1415177
    [No Abstract]   [Full Text] [Related]  

  • 7. Minimal change glomerulonephritis with reversible proteinuria during interferon alpha 2a therapy for chronic myeloid leukemia.
    Rettmar K; Kienast J; van de Loo J
    Am J Hematol; 1995 Aug; 49(4):355-6. PubMed ID: 7639284
    [No Abstract]   [Full Text] [Related]  

  • 8. Acral sclerosis due to interferon-alpha-2b in chronic myelogenous leukemia.
    Saydam G; Bozkurt D; Sahin F; Yuksel S; Hekimgil M; Omay SB; Buyukkececi F
    Acta Haematol; 2002; 107(1):43-5. PubMed ID: 11818672
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of myasthenia gravis during interferon-alpha treatment for anti-HCV positive chronic hepatitis.
    Mase G; Zorzon M; Biasutti E; Vitrani B; Cazzato G; Urban F; Frezza M
    J Neurol Neurosurg Psychiatry; 1996 Mar; 60(3):348-9. PubMed ID: 8609521
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombotic thrombocytopenic purpura complicating chronic myelogenous leukemia treated with interferon-alpha. A report of two successfully treated patients.
    Rachmani R; Avigdor A; Youkla M; Raanani P; Zilber M; Ravid M; Ben-Bassat I
    Acta Haematol; 1998; 100(4):204-6. PubMed ID: 9973644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal thrombotic microangiopathy induced by interferon-alpha.
    Badid C; McGregor B; Faivre JM; Guerard A; Juillard L; Fouque D; Laville M
    Nephrol Dial Transplant; 2001 Apr; 16(4):846-8. PubMed ID: 11274286
    [No Abstract]   [Full Text] [Related]  

  • 12. Exacerbation of myasthenia gravis during interferon-alpha treatment.
    Uyama E; Fujiki N; Uchino M
    J Neurol Sci; 1996 Dec; 144(1-2):221-2. PubMed ID: 8994129
    [No Abstract]   [Full Text] [Related]  

  • 13. Retinopathy is not the only ocular symptom: myasthenia gravis in association with interferon therapy.
    Oishi A; Miyamoto K; Kashii S; Yoshimura N
    Br J Ophthalmol; 2005 Nov; 89(11):1542-3. PubMed ID: 16234478
    [No Abstract]   [Full Text] [Related]  

  • 14. [Myasthenia during interferon alpha therapy].
    Quilichini R; Mazzerbo F; Baume D; Amiel O; Lafeuillade A; Pellegrino P
    Presse Med; 1995 Sep 2-9; 24(25):1178. PubMed ID: 7567837
    [No Abstract]   [Full Text] [Related]  

  • 15. Myasthenia gravis in a patient with chronic active hepatitis C during interferon-alpha treatment.
    Piccolo G; Franciotta D; Versino M; Alfonsi E; Lombardi M; Poma G
    J Neurol Neurosurg Psychiatry; 1996 Mar; 60(3):348. PubMed ID: 8609520
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of Myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin.
    Bektas M; Bektas H; Gören D; Altan M; Cetinkaya H
    Digestion; 2007; 75(4):208-9. PubMed ID: 17934275
    [No Abstract]   [Full Text] [Related]  

  • 17. Acquired factor VIII inhibitor as presentation of chronic myelogenous leukemia during interferon-alpha therapy.
    Zheng WL; Zhang GS; Shen JK; Pei MF; Peng HL; Xu M
    Thromb Res; 2011 Aug; 128(2):202-3. PubMed ID: 21621826
    [No Abstract]   [Full Text] [Related]  

  • 18. Myasthenia gravis following IFN-alpha-2a treatment.
    Bora I; Karli N; Bakar M; Zarifoğlu M; Turan F; Oğul E
    Eur Neurol; 1997; 38(1):68. PubMed ID: 9252802
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe autoimmune thrombocytopenic purpura during interferon-alpha therapy for chronic myelogenous leukemia.
    Arimura K; Arima N; Ohtsubo H; Matsushita K; Kukita T; Ayukawa T; Kuroki T; Tei C
    Acta Haematol; 2004; 112(4):217-8. PubMed ID: 15564735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myeloid leukemia presenting as paraneoplastic ocular myasthenia gravis.
    Kumar P; Jain P; Menon H; Purvish P
    Ann Oncol; 2007 Apr; 18(4):804-5. PubMed ID: 17389528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.